Yan Song1,2, Elizabeth L Chou3, Aileen Baecker1, Nai-Chieh Y You1, Yiqing Song4, Qi Sun5,6, Simin Liu2,7. 1. Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, California, USA. 2. Department of Epidemiology, School of Public Health, Providence, Rhode Island, USA. 3. Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA. 4. Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, USA. 5. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. 6. Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. 7. Department of Medicine, Alpert Medical School, Brown University, Providence, Rhode Island, USA.
Abstract
BACKGROUND: Elevated blood or urinary concentrations of endocrine-disrupting chemicals (EDCs) may be related to increased risk of type 2 diabetes (T2D). The aim of the present study was to assess the role of EDCs in affecting risk of T2D and related metabolic traits. METHODS: MEDLINE was searched for cross-sectional and prospective studies published before 8 March 2014 into the association between EDCs (dioxin, polychlorinated biphenyl [PCB], chlorinated pesticide, bisphenol A [BPA], phthalate) and T2D and related metabolic traits. Three investigators independently extracted information on study design, participant characteristics, EDC types and concentrations, and association measures. RESULTS: Forty-one cross-sectional and eight prospective studies from ethnically diverse populations were included in the analysis. Serum concentrations of dioxins, PCBs, and chlorinated pesticides were significantly associated with T2D risk; comparing the highest to lowest concentration category, the pooled relative risks (RR) were 1.91 (95% confidence interval [CI] 1.44-2.54) for dioxins, 2.39 (95% CI 1.86-3.08) for total PCBs, and 2.30 (95% CI 1.81-2.93) for chlorinated pesticides. Urinary concentrations of BPA and phthalates were also associated with T2D risk; comparing the highest to lowest concentration categories, the pooled RR were 1.45 (95% CI 1.13-1.87) for BPA and 1.48 (95% CI 0.98-2.25) for phthalates. Further, EDC concentrations were associated with indicators of impaired fasting glucose and insulin resistance. CONCLUSIONS: Persistent and non-persistent EDCs may affect the risk of T2D. There is an urgent need for further investigation of EDCs, especially non-persistent ones, and T2D risk in large prospective studies.
BACKGROUND: Elevated blood or urinary concentrations of endocrine-disrupting chemicals (EDCs) may be related to increased risk of type 2 diabetes (T2D). The aim of the present study was to assess the role of EDCs in affecting risk of T2D and related metabolic traits. METHODS: MEDLINE was searched for cross-sectional and prospective studies published before 8 March 2014 into the association between EDCs (dioxin, polychlorinated biphenyl [PCB], chlorinated pesticide, bisphenol A [BPA], phthalate) and T2D and related metabolic traits. Three investigators independently extracted information on study design, participant characteristics, EDC types and concentrations, and association measures. RESULTS: Forty-one cross-sectional and eight prospective studies from ethnically diverse populations were included in the analysis. Serum concentrations of dioxins, PCBs, and chlorinated pesticides were significantly associated with T2D risk; comparing the highest to lowest concentration category, the pooled relative risks (RR) were 1.91 (95% confidence interval [CI] 1.44-2.54) for dioxins, 2.39 (95% CI 1.86-3.08) for total PCBs, and 2.30 (95% CI 1.81-2.93) for chlorinated pesticides. Urinary concentrations of BPA and phthalates were also associated with T2D risk; comparing the highest to lowest concentration categories, the pooled RR were 1.45 (95% CI 1.13-1.87) for BPA and 1.48 (95% CI 0.98-2.25) for phthalates. Further, EDC concentrations were associated with indicators of impaired fasting glucose and insulin resistance. CONCLUSIONS: Persistent and non-persistent EDCs may affect the risk of T2D. There is an urgent need for further investigation of EDCs, especially non-persistent ones, and T2D risk in large prospective studies.
Authors: Rachel M Shaffer; Kelly K Ferguson; Lianne Sheppard; Tamarra James-Todd; Samantha Butts; Suchitra Chandrasekaran; Shanna H Swan; Emily S Barrett; Ruby Nguyen; Nicole Bush; Thomas F McElrath; Sheela Sathyanarayana Journal: Environ Int Date: 2019-01-07 Impact factor: 9.621
Authors: Kristen J Polinski; Dana Dabelea; Richard F Hamman; John L Adgate; Antonia M Calafat; Xiaoyun Ye; Anne P Starling Journal: Environ Res Date: 2018-02-04 Impact factor: 6.498
Authors: Jane S Burns; Paige L Williams; Oleg Sergeyev; Susan A Korrick; Sergey Rudnev; Bora Plaku-Alakbarova; Boris Revich; Russ Hauser; Mary M Lee Journal: Int J Hyg Environ Health Date: 2019-08-26 Impact factor: 5.840
Authors: L A Koneva; A K Vyas; R C McEachin; M Puttabyatappa; H-S Wang; M A Sartor; V Padmanabhan Journal: Environ Mol Mutagen Date: 2017-01-12 Impact factor: 3.216
Authors: Karla L Hernández-Hernández; Natalia Tapia-Orozco; Miquel Gimeno; Ana María Espinosa-García; José Antonio García-García; Daniela Araiza-Olivera; Francisco Sánchez-Bartez; Isabel Gracia-Mora; Manuel Gutierrez-Aguilar; Roeb García-Arrazola Journal: Mol Biol Rep Date: 2019-02-07 Impact factor: 2.316